22nd Century Group, Inc. XXII
We take great care to ensure that the data presented and summarized in this overview for 22nd Century Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding XXII
View all-
ETF Managers Group, LLC Summit, NJ1.22MShares$6.81 Million0.03% of portfolio
-
Gofen & Glossberg LLC50KShares$280,0000.0% of portfolio
-
Private Capital Group, LLC558Shares$3,1240.0% of portfolio
-
Ahrens Investment Partners LLC200Shares$1,1200.0% of portfolio
-
Bar Harbor Trust Services Ellsworth, ME0Shares$0100.0% of portfolio
Latest Institutional Activity in XXII
Top Purchases
Top Sells
About XXII
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Insider Transactions at XXII
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2024
|
Lawrence Firestone Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
39,000
+41.82%
|
$0
$0.27 P/Share
|
|
May 30
2024
|
Lawrence Firestone Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,000
+37.11%
|
$9,000
$1.09 P/Share
|
|
Jan 05
2024
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$0
$0.17 P/Share
|
|
Jan 04
2024
|
Lawrence Firestone Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$0
$0.17 P/Share
|
|
Mar 21
2023
|
John Franzino Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,244
-2.3%
|
$0
$0.87 P/Share
|
|
Mar 21
2023
|
James A Mish Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
225,841
-9.55%
|
$0
$0.87 P/Share
|
|
Mar 19
2023
|
John Franzino Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,210
-3.31%
|
$0
$0.87 P/Share
|
|
Mar 19
2023
|
James A Mish Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
54,735
-2.26%
|
$0
$0.87 P/Share
|
|
Mar 14
2023
|
Robert Hugh Kinsman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
275,698
+45.67%
|
-
|
|
Mar 14
2023
|
John J Miller President, Tobacco |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+40.0%
|
-
|
|
Mar 14
2023
|
Peter Ferola Chief Legal Officer & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
308,972
+50.0%
|
-
|
|
Mar 14
2023
|
Anthony L. Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
128,342
+36.83%
|
-
|
|
Mar 14
2023
|
James A Mish Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
431,730
+15.15%
|
-
|
|
Mar 14
2023
|
Richard M. Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
128,342
+18.31%
|
-
|
|
Mar 14
2023
|
Nora B Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
128,342
+12.77%
|
-
|
|
Mar 14
2023
|
John Franzino Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
235,829
+26.88%
|
-
|
|
Mar 14
2023
|
Lucille S Salhany Director |
BUY
Grant, award, or other acquisition
|
Direct |
128,342
+45.14%
|
-
|
|
Mar 14
2023
|
Michael Koganov Director |
BUY
Grant, award, or other acquisition
|
Direct |
128,342
+29.43%
|
-
|
|
Sep 21
2022
|
Lucille S Salhany Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,612
+50.0%
|
-
|
|
Aug 31
2022
|
Michael Zercher President and COO |
SELL
Open market or private sale
|
Direct |
370,789
-29.06%
|
$370,789
$1.35 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 248K shares |
|---|